Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Moher

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Evidence Report/Technology Assessment (Summary)|September 7, 2004
Celiac diseaseA Rostom, C Dubé, A Cranney, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 1999
Synthesis and biological evaluation of cryptophycin analogs with substitution at C-6 (fragment C region)D L Varie, C Shih, D A Hay, et al.
BMJ (Clinical Research Ed.)|August 4, 2017
GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in researchS Staniszewska, J Brett, I Simera, et al.
Evidence Report/Technology Assessment (Summary)|August 23, 2005
Acute stroke: evaluation and treatmentM Sharma, H Clark, T Armour, et al.
Research Involvement and Engagement|October 25, 2017
GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in researchS Staniszewska, J Brett, I Simera, et al.
Health Technology Assessment (Winchester, England)|September 20, 2012
Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studiesJ Savović, He Jones, Dg Altman, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|January 30, 2016
[Better Reporting of Interventions: Template for Intervention Description and Replication (TIDieR) Checklist and Guide]T C Hoffmann, P P Glasziou, I Boutron, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|January 4, 2018
[Better Reporting of Interventions: Template for Intervention Description and Replication (TIDieR) Checklist and Guide]T C Hoffmann, P P Glasziou, I Boutron, et al.
Journal of Medicinal Chemistry|January 9, 2004
(2S,1'S,2'R,3'R)-2-(2'-Carboxy-3'-hydroxymethylcyclopropyl) glycine is a highly potent group 2 and 3 metabotropic glutamate receptor agonist with oral activityIván Collado, Concepción Pedregal, Ana Belén Bueno, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|April 16, 2011
Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndromeJ Feber, I Gaboury, A Ni, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Evidence Report/Technology Assessment (Summary)|September 7, 2004
Celiac diseaseA Rostom, C Dubé, A Cranney, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 1999
Synthesis and biological evaluation of cryptophycin analogs with substitution at C-6 (fragment C region)D L Varie, C Shih, D A Hay, et al.
BMJ (Clinical Research Ed.)|August 4, 2017
GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in researchS Staniszewska, J Brett, I Simera, et al.
Evidence Report/Technology Assessment (Summary)|August 23, 2005
Acute stroke: evaluation and treatmentM Sharma, H Clark, T Armour, et al.
Research Involvement and Engagement|October 25, 2017
GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in researchS Staniszewska, J Brett, I Simera, et al.
Health Technology Assessment (Winchester, England)|September 20, 2012
Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studiesJ Savović, He Jones, Dg Altman, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|January 30, 2016
[Better Reporting of Interventions: Template for Intervention Description and Replication (TIDieR) Checklist and Guide]T C Hoffmann, P P Glasziou, I Boutron, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|January 4, 2018
[Better Reporting of Interventions: Template for Intervention Description and Replication (TIDieR) Checklist and Guide]T C Hoffmann, P P Glasziou, I Boutron, et al.
Journal of Medicinal Chemistry|January 9, 2004
(2S,1'S,2'R,3'R)-2-(2'-Carboxy-3'-hydroxymethylcyclopropyl) glycine is a highly potent group 2 and 3 metabotropic glutamate receptor agonist with oral activityIván Collado, Concepción Pedregal, Ana Belén Bueno, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|April 16, 2011
Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndromeJ Feber, I Gaboury, A Ni, et al.
Pageof 13